Psoriasis can occur near the eyes, causing redness, itching, dryness, and flaking skin. Once it’s correctly diagnosed, you can often manage it with topical treatments.

A new subgroup analysis reveals that adolescents with moderate-to-severe plaque psoriasis treated with once-daily icotrokinra ...

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

AbbVie, Thermo Fisher Scientific, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to ...

Researchers have found in a recent analysis reveals IL-17 inhibitors significantly increase the risk of Candida infections ...

The autoimmune disease causes raised, scaly patches of skin. As a child, it left the football star embarrassed to remove his ...

Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

Compared with adalimumab, several biologic medications had superior safety profiles for the treatment of moderate to severe psoriasis.

A rare case of adalimumab-induced pustular psoriasis in a hidradenitis suppurativa patient was successfully treated with ...

Coming off a Super Bowl victory, Eagles tight end Dallas Goedert sat down with Newsweek to discuss his plaque psoriasis and ...

New data from the POETYK PsA-Phase III trial, presented at the 2025 EULAR Congress, demonstrate that Bristol Myers Squibb’s Sotyktu (deucravacitinib) significantly improves joint and skin symptoms in ...